Skip to main content
SpringerLink
Log in

Bronchopulmonary Dysplasia: Clinical Management

  • Chapter
  • First Online:
Manual of Neonatal Respiratory Care

  • 1062 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12–28.

    Article  Google Scholar 

  • Aschner JL. New therapies for pulmonary hypertension in neonates and children. Pediatr Pulmonol. 2004;37(Suppl. 26):132–5.

    Article  Google Scholar 

  • Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349:959–67.

    Article  CAS  Google Scholar 

  • Atkinson SA. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr. 2001;131:942S–6S.

    Article  CAS  Google Scholar 

  • Bancalari E, editor. Bronchopulmonary dysplasia. Semin Perinatol. 2003;8:1–92.

    Google Scholar 

  • Brunton JA, Saigal S, Atkinson S. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr. 1998;133:340–5.

    Article  CAS  Google Scholar 

  • Buzzella B, Claure N, D’Ugard C, Bancalari E. A randomized controlled trial of two nasal continuous positive airway pressure levels after extubation in preterm infants. J Pediatr. 2014;164:46–51.

    Article  Google Scholar 

  • Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med. 1999;340:1005–10.

    Article  CAS  Google Scholar 

  • D’Angio CT, Maniscalco WM. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. Paediatr Drugs. 2004;6:303–30.

    Article  Google Scholar 

  • Doyle LW, Ehrenkranz RA, Halliday HL. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology. 2010;98:111–7.

    Article  CAS  Google Scholar 

  • Grier DG, Halliday HL. Corticosteroids in the prevention and management of BPD. Semin Neonatol. 2003;8:83–91.

    Article  Google Scholar 

  • Kao LC, Durand DJ, McCrea RC, et al. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr. 1994;124:772–81.

    Article  CAS  Google Scholar 

  • Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J Pediatr. 2017;188:24–34.

    Article  Google Scholar 

  • Michael Z, Spyropoulos F, Ghanta S, Christou H. Bronchopulmonary dysplasia: an update of current pharmacologic therapies and new approaches. Clin Med Insights Pediatr. 2018;12:1–12.

    Article  Google Scholar 

  • Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009;154(3):379–84.

    Article  CAS  Google Scholar 

  • O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104:15–21.

    Article  CAS  Google Scholar 

  • Onland W, Offringa M, De Jaegere AP, van Kaam AH. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials. Pediatrics. 2009;123:367–77.

    Article  Google Scholar 

  • Poets CF, Lorenz L. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence. Arch Dis Child Fetal Neonatal Ed. 2018;103:F285–91.

    Article  Google Scholar 

  • Reyes Z, Tauscher M, Claure N. Randomized, controlled trial comparing pressure support (PS) + synchronized intermittent mandatory ventilation (SIMV) with SIMV in preterm infants. Pediatr Res. 2004;55:466A.

    Article  Google Scholar 

  • Schmidt B, Roberts R, Millar D, Kirpalani H. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology. 2008;93:284–7.

    Article  Google Scholar 

  • Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012 for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. JAMA. 2015;314(10):1039–51.

    Article  CAS  Google Scholar 

  • SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970–9.

    Article  Google Scholar 

  • Tyson JE, Wright LL, Oh W, et al. Vitamin a supplementation for extremely-low-birth-weight infants. N Engl J Med. 1999;340:1962–8.

    Article  CAS  Google Scholar 

  • Wardle AJ, Wardle R, Luyt K, et al. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia. Arch Dis Child. 2013;98:613–7.

    Article  Google Scholar 

  • Watterberg KL, Committee on Fetus and Newborn. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics. 2010;126:800–8.

    Article  Google Scholar 

  • Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004;350:1304–13.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Miami Miller School of Medicine, Miami, FL, USA

    Eduardo Bancalari

Authors
  1. Eduardo Bancalari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Bancalari .

Editor information

Editors and Affiliations

  1. Division of Neonatal-Perinatal Medicine, C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI, USA

    Steven M. Donn

  2. Division of Neonatology, University of Minnesota, Minneapolis, MN, USA

    Mark C. Mammel

  3. Department of Neonatology, Emma Children’s Hospital Amsterdam UMC University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands

    Anton H.L.C. van Kaam

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bancalari, E. (2022). Bronchopulmonary Dysplasia: Clinical Management. In: Donn, S.M., Mammel, M.C., van Kaam, A.H. (eds) Manual of Neonatal Respiratory Care. Springer, Cham. https://doi.org/10.1007/978-3-030-93997-7_79

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-93997-7_79

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-93996-0

  • Online ISBN: 978-3-030-93997-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation